Regular Compensation & Benefits Leaders Group Meets for Quarterly Trends Discussion

The Chapman Consulting Group were delighted to co-host a lively C&B Directors Q2 Market update with AstraZeneca last week. Jenny Teo, Regional Rewards Head of AstraZeneca, hosted the session. The session brought together over 30 C&B leaders with APAC (and in some cases International) remit. Representatives attended from a variety of companies, including Hilton, Hitachi, Energizer, Abbott Labs, BHP Billiton, Deutsche Bank, Aviva, GSK, Singtel, Microsoft and many more.

Having a broad mix of attendees from banking, pharmaceutical, consumer goods, hospitality and technology industries served to help spark plenty of idea sharing. Matt Chapman, CEO of The Chapman Consulting Group, chaired the session and outlined the latest C&B trends since the last gathering in January. Bonus payments, 2012 budget confirmation and reduced demand in the financial services space has slowed things down. C&B talent remains in short supply around the region and C&B Leaders are having to be very creative to build their teams.

More leaders are thinking about inter-Asian movements of C&B talent (so switching high potential C&B talent out in the countries into the regional locations for development). Other leaders are asking for external European and Australian/NZ talent to relocate into Singapore (ideally on local terms). The group debated mobility strategy, expat transition challenges (from expat packages to local remuneration) and had contrasting views on total reward management from industry to industry.

The next meeting of the group will take place at GlaxoSmithKline (GSK) and will be hosted by Lynette Ng, Global Rewards Lead) for GSK.